Abstract
The administration of glucorticoids is currently the standard pharmacological treatment prescribed for patients with Duchenne muscular disease (DMD). Due to its side effects, the search for alternative therapies that minimize the evolution of the disease and improve the quality of life of dystrophic patients is necessary. In this context, we hypothesized that the combination of photobiomo…